Pharma cos marketing medicines made by third parties to soon be liable for quality lapses flagged by CDSCO

The move is expected to check lapses in quality of medicines consumed by patients in the country, according to persons aware of the development.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news